The mechanism responsible for lipid-induced hepatic insulin resistance has been attributed to hepatic DAG activating PKCε, which promotes insulin receptor kinase threonine1160 (mouse threonine1150) phosphorylation, thereby inhibiting insulin-stimulated insulin receptor kinase tyrosine phosphorylation (11). The gene discussed is INS; the disease is Insulin resistance.